APA (7th ed.) Citation

Albuquerque, C. P., Freitas, F. R., Martinelli, A. E. M., Lima, J. H., Coelho, R. F., Serrano Jr., C. V., . . . Maranhão, R. C. (2020). Androgen deprivation therapy improves the in vitro capacity of high-density lipoprotein (HDL) to receive cholesterol and other lipids in patients with prostate carcinoma. Lipids in Health & Disease, 19(1), 1. https://doi.org/10.1186/s12944-020-01305-8

Chicago Style (17th ed.) Citation

Albuquerque, Cicero P., Fatima R. Freitas, Ana Elisa M. Martinelli, Josefa H. Lima, Rafael F. Coelho, Carlos V. Serrano Jr., Willian C. Nahas, Roberto Kalil Filho, and Raul C. Maranhão. "Androgen Deprivation Therapy Improves the in Vitro Capacity of High-density Lipoprotein (HDL) to Receive Cholesterol and Other Lipids in Patients with Prostate Carcinoma." Lipids in Health & Disease 19, no. 1 (2020): 1. https://doi.org/10.1186/s12944-020-01305-8.

MLA (9th ed.) Citation

Albuquerque, Cicero P., et al. "Androgen Deprivation Therapy Improves the in Vitro Capacity of High-density Lipoprotein (HDL) to Receive Cholesterol and Other Lipids in Patients with Prostate Carcinoma." Lipids in Health & Disease, vol. 19, no. 1, 2020, p. 1, https://doi.org/10.1186/s12944-020-01305-8.